IRIS
PIRISI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.233
NA - Nord America 9.961
AS - Asia 7.031
SA - Sud America 1.304
AF - Africa 297
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
AN - Antartide 1
Totale 29.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.657
IE - Irlanda 2.770
SG - Singapore 2.460
IT - Italia 1.718
DE - Germania 1.565
HK - Hong Kong 1.341
SE - Svezia 1.315
CN - Cina 1.190
BR - Brasile 1.030
UA - Ucraina 937
FR - Francia 776
RU - Federazione Russa 765
VN - Vietnam 719
FI - Finlandia 488
IN - India 442
GB - Regno Unito 304
KR - Corea 234
CA - Canada 194
BJ - Benin 139
ID - Indonesia 136
CZ - Repubblica Ceca 132
AR - Argentina 113
AT - Austria 94
PL - Polonia 94
TR - Turchia 88
MX - Messico 80
ZA - Sudafrica 71
BD - Bangladesh 69
JP - Giappone 64
IR - Iran 61
NL - Olanda 61
ES - Italia 60
BE - Belgio 47
IQ - Iraq 38
EC - Ecuador 37
CL - Cile 35
PK - Pakistan 33
LT - Lituania 32
EG - Egitto 23
VE - Venezuela 22
CO - Colombia 20
EU - Europa 20
PE - Perù 18
PY - Paraguay 18
CH - Svizzera 15
AU - Australia 14
MA - Marocco 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
KE - Kenya 12
NP - Nepal 12
MY - Malesia 11
UZ - Uzbekistan 11
RO - Romania 10
TN - Tunisia 10
TW - Taiwan 10
NG - Nigeria 9
PH - Filippine 8
OM - Oman 7
TH - Thailandia 7
AL - Albania 6
DO - Repubblica Dominicana 6
JO - Giordania 6
UY - Uruguay 6
AZ - Azerbaigian 5
BH - Bahrain 5
DZ - Algeria 5
KZ - Kazakistan 5
PT - Portogallo 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
GE - Georgia 4
JM - Giamaica 4
LB - Libano 4
LK - Sri Lanka 4
MO - Macao, regione amministrativa speciale della Cina 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
GR - Grecia 3
GT - Guatemala 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
Totale 29.832
Salva come PNG Salva come JPEG
Città #
Dublin 2.751
Jacksonville 1.657
Hong Kong 1.324
Singapore 806
Dearborn 733
Ashburn 692
Chandler 603
Beijing 602
Wilmington 431
Novara 344
Princeton 333
Lawrence 332
Los Angeles 331
Moscow 279
San Mateo 252
Ann Arbor 241
Ho Chi Minh City 227
Munich 224
Piemonte 216
Buffalo 206
Seoul 205
Milan 159
New York 148
Cotonou 139
Hanoi 136
São Paulo 132
Andover 130
Houston 113
Boardman 108
Turin 94
Jakarta 90
Helsinki 86
Dallas 81
Nuremberg 79
Brno 73
Santa Clara 71
Warsaw 71
Woodbridge 71
Vercelli 70
Chennai 69
Frankfurt am Main 68
Denver 67
Redondo Beach 66
Bremen 65
Brooklyn 62
Montreal 62
Dong Ket 60
London 60
Poplar 60
Nanjing 59
Orem 59
Johannesburg 53
Turku 53
Stockholm 50
Tokyo 50
Toronto 50
Hefei 49
Atlanta 48
Brussels 45
Philadelphia 42
Boston 40
Phoenix 40
Seattle 39
Tianjin 39
Vienna 38
Düsseldorf 37
Falkenstein 36
Mexico City 34
Pardubice 34
Norwalk 33
Ankara 32
Chicago 31
Da Nang 30
Kunming 28
Mumbai 28
Kocaeli 27
Biên Hòa 25
Rome 25
Amsterdam 24
Rio de Janeiro 24
Guangzhou 23
Haiphong 23
Hải Dương 23
Manchester 23
Torino 23
Mülheim 22
Querétaro 21
Brasília 20
Curitiba 20
Monmouth Junction 20
Alessandria 19
Salvador 19
Assago 18
Augusta 18
Fairfield 18
Jinan 18
Porto Alegre 18
Dhaka 17
Nanchang 17
Ottawa 17
Totale 16.878
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 332
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 263
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 208
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 206
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation 176
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 152
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 144
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 139
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 139
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 136
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 136
Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients 136
Change over time of COVID-19 hospital presentation in Northern Italy 135
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 133
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 132
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 131
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 129
Role of beta-blockers in patients with COPD: current perspective. 126
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 124
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 124
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 123
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 122
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 120
Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome 120
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 120
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 120
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 120
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 118
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 116
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 115
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 114
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 113
Pattern of emergency department referral during the Covid-19 outbreak in Italy 112
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 111
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 111
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 111
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 111
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 111
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 110
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 110
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 110
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 109
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 108
Vitamin D in Systemic Sclerosis: A Review 107
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 107
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 107
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 106
Diagnostic value of FibroTest with normal serum aminotransferases 104
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 103
Influence of age on sex-related differences among patients with hepatitis C. 103
One-Year Follow up of Noninvasive Respiratory Support in General Wards 102
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 102
4. Association between release of tumor necrosis factor and response to interferon therapy in chronic hepatitis C 102
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 102
First reported human case of meningitis by Staphylococcus condimenti 102
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 102
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 101
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 100
An unusual adverse reaction to iodine-based contrast agent. 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
A woman with anemia and a small bowel obstruction 98
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 98
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 98
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 98
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 97
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 96
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 96
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 96
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 95
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 95
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 95
Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes 94
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 94
Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice 94
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 93
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 93
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 93
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 93
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 93
A case of false positive troponin I in a patient affected by cryoglobulinemic vasculitis 92
Eosinophilic gastroenteritis in pregnancy: A review of the literature 92
(Letter) Membranoproliferative glomerulonephritis associated with Hepatitis C infection with no evidence of liver disease 91
Recent advances in HCV entry 91
Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome. 91
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 91
Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication 91
Understanding protection from SARS-CoV-2 using metabolomics 91
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 91
A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions 91
ACE genotype, body weight changes and target organ damage in renal transplant recipients 91
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 90
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 90
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 90
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 89
Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease 89
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 89
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 89
A rare cause of intractable diarrhea 89
Boceprevir for untreated chronic HCV genotype 1 infection 89
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis 89
Totale 11.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.342 0 0 0 0 0 97 317 50 326 77 363 112
2021/20222.287 101 58 459 228 112 28 168 80 196 104 284 469
2022/20235.518 502 220 276 151 299 444 165 234 2.846 34 226 121
2023/20242.593 140 341 151 77 394 74 490 134 54 86 249 403
2024/20255.293 135 65 262 144 146 336 525 545 1.202 493 390 1.050
2025/20267.547 780 666 1.148 2.455 1.718 780 0 0 0 0 0 0
Totale 30.571